KPNA2 and Miyoshi myopathy: In this context, Albrecht et al. identified cfRNA biomarkers (KPNA2, DTL, BACE2, and DTYMK) that were significantly higher in MM patient plasma compared to healthy donor plasma (p < 0.0001) [66].